Literature DB >> 17561409

Abnormal motor phenotype in the SMNDelta7 mouse model of spinal muscular atrophy.

Matthew E R Butchbach1, Jonathan D Edwards, Arthur H M Burghes.   

Abstract

Spinal muscular atrophy (SMA) is a recessive motor neuron disease that affects motor neurons in the anterior horn of the spinal cord. SMA results from the reduction of SMN (survival motor neuron) protein. Even though SMN is ubiquitously expressed, motor neurons are more sensitive to the reduction in SMN than other cell types. We have previously generated mouse models of SMA with varying degrees of clinical severity. So as to more clearly understand the pathogenesis of motor neuron degeneration in SMA, we have characterized the phenotype of the SMNDelta7 SMA mouse which normally lives for 13.6+/-0.7 days. These mice are smaller than their non-SMA littermates and begin to lose body mass at 10.4+/-0.4 days. SMNDelta7 SMA mice exhibit impaired responses to surface righting, negative geotaxis and cliff aversion but not to tactile stimulation. Spontaneous motor activity and grip strength are also significantly impaired in SMNDelta7 SMA mice. In summary, we have demonstrated an impairment of neonatal motor responses in SMNDelta7 SMA mice. This phenotype characterization could be used to assess the effectiveness of potential therapies for SMA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17561409      PMCID: PMC2700002          DOI: 10.1016/j.nbd.2007.04.009

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  57 in total

Review 1.  Sample size calculations for randomized controlled trials.

Authors:  Janet Wittes
Journal:  Epidemiol Rev       Date:  2002       Impact factor: 6.222

2.  Sample size determination.

Authors:  Ralph B Dell; Steve Holleran; Rajasekhar Ramakrishnan
Journal:  ILAR J       Date:  2002

3.  Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome.

Authors:  X Altafaj; M Dierssen; C Baamonde; E Martí; J Visa; J Guimerà; M Oset; J R González; J Flórez; C Fillat; X Estivill
Journal:  Hum Mol Genet       Date:  2001-09-01       Impact factor: 6.150

4.  Effects of chronic and acute methylphenidate hydrochloride (Ritalin) administration on locomotor activity, ultrasonic vocalizations, and neuromotor development in 3- to 11-day-old CD-1 mouse pups.

Authors:  M R Penner; M P McFadyen; N Carrey; R E Brown
Journal:  Dev Psychobiol       Date:  2001-11       Impact factor: 3.038

5.  An intrinsic distinction in neuromuscular junction assembly and maintenance in different skeletal muscles.

Authors:  San Pun; Markus Sigrist; Alexandre F Santos; Markus A Ruegg; Joshua R Sanes; Thomas M Jessell; Silvia Arber; Pico Caroni
Journal:  Neuron       Date:  2002-04-25       Impact factor: 17.173

6.  Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model.

Authors:  Carmen Cifuentes-Diaz; Sophie Nicole; Maria E Velasco; Christophe Borra-Cebrian; Cristina Panozzo; Tony Frugier; Gaelle Millet; Natacha Roblot; Vandana Joshi; Judith Melki
Journal:  Hum Mol Genet       Date:  2002-06-01       Impact factor: 6.150

7.  Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number.

Authors:  D W Parsons; P E McAndrew; S T Iannaccone; J R Mendell; A H Burghes; T W Prior
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

8.  Neurobehavioral development of two mouse lines commonly used in transgenic studies.

Authors:  M Dierssen; V Fotaki; M Martínez de Lagrán; M Gratacós; M Arbonés; C Fillat; X Estivill
Journal:  Pharmacol Biochem Behav       Date:  2002-08       Impact factor: 3.533

9.  Intact satellite cells lead to remarkable protection against Smn gene defect in differentiated skeletal muscle.

Authors:  Sophie Nicole; Benedicte Desforges; Gaelle Millet; Jeanne Lesbordes; Carmen Cifuentes-Diaz; Dora Vertes; My Linh Cao; Fabienne De Backer; Laetitia Languille; Natacha Roblot; Vandana Joshi; Jean-Marie Gillis; Judith Melki
Journal:  J Cell Biol       Date:  2003-05-12       Impact factor: 10.539

10.  A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy.

Authors:  Umrao R Monani; Matthew T Pastore; Tatiana O Gavrilina; Sibylle Jablonka; Thanh T Le; Catia Andreassi; Jennifer M DiCocco; Christian Lorson; Elliot J Androphy; Michael Sendtner; Michael Podell; Arthur H M Burghes
Journal:  J Cell Biol       Date:  2003-01-06       Impact factor: 10.539

View more
  64 in total

1.  IPLEX administration improves motor neuron survival and ameliorates motor functions in a severe mouse model of spinal muscular atrophy.

Authors:  Michela Murdocca; Arianna Malgieri; Andrea Luchetti; Luciano Saieva; Gabriella Dobrowolny; Elvira de Leonibus; Antonio Filareto; Maria Chiara Quitadamo; Giuseppe Novelli; Antonio Musarò; Federica Sangiuolo
Journal:  Mol Med       Date:  2012-09-25       Impact factor: 6.354

2.  The effect of diet on the protective action of D156844 observed in spinal muscular atrophy mice.

Authors:  Matthew E R Butchbach; Jasbir Singh; Mark E Gurney; Arthur H M Burghes
Journal:  Exp Neurol       Date:  2014-03-25       Impact factor: 5.330

3.  Low levels of Survival Motor Neuron protein are sufficient for normal muscle function in the SMNΔ7 mouse model of SMA.

Authors:  Chitra C Iyer; Vicki L McGovern; Jason D Murray; Sara E Gombash; Phillip G Zaworski; Kevin D Foust; Paul M L Janssen; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2015-08-13       Impact factor: 6.150

4.  Muscles in a mouse model of spinal muscular atrophy show profound defects in neuromuscular development even in the absence of failure in neuromuscular transmission or loss of motor neurons.

Authors:  Young Il Lee; Michelle Mikesh; Ian Smith; Mendell Rimer; Wesley Thompson
Journal:  Dev Biol       Date:  2011-05-30       Impact factor: 3.582

5.  Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy.

Authors:  Ferrill F Rose; Virginia B Mattis; Hansjörg Rindt; Christian L Lorson
Journal:  Hum Mol Genet       Date:  2008-12-12       Impact factor: 6.150

6.  Systemic administration of a recombinant AAV1 vector encoding IGF-1 improves disease manifestations in SMA mice.

Authors:  Li-Kai Tsai; Chien-Lin Chen; Chen-Hung Ting; Sue Lin-Chao; Wuh-Liang Hwu; James C Dodge; Marco A Passini; Seng H Cheng
Journal:  Mol Ther       Date:  2014-05-12       Impact factor: 11.454

7.  Astrocytes influence the severity of spinal muscular atrophy.

Authors:  Hansjörg Rindt; Zhihua Feng; Chiara Mazzasette; Jacqueline J Glascock; David Valdivia; Noah Pyles; Thomas O Crawford; Kathryn J Swoboda; Teresa N Patitucci; Allison D Ebert; Charlotte J Sumner; Chien-Ping Ko; Christian L Lorson
Journal:  Hum Mol Genet       Date:  2015-04-24       Impact factor: 6.150

8.  Synaptic defects in the spinal and neuromuscular circuitry in a mouse model of spinal muscular atrophy.

Authors:  Karen K Y Ling; Ming-Yi Lin; Brian Zingg; Zhihua Feng; Chien-Ping Ko
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

9.  Effect of diet on the survival and phenotype of a mouse model for spinal muscular atrophy.

Authors:  Matthew E R Butchbach; Ferrill F Rose; Sarah Rhoades; John Marston; John T McCrone; Rachel Sinnott; Christian L Lorson
Journal:  Biochem Biophys Res Commun       Date:  2009-11-27       Impact factor: 3.575

10.  Subcutaneous administration of TC007 reduces disease severity in an animal model of SMA.

Authors:  Virginia B Mattis; Marina Y Fosso; Cheng-Wei Chang; Christian L Lorson
Journal:  BMC Neurosci       Date:  2009-11-30       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.